|
XB--5993002
Papers associated with kcnt1 (and Disease Ontology)
???pagination.result.count???
???pagination.result.page??? 1
| Sort Newest To Oldest | Sort Oldest To Newest |
Advancements in the use of xenopus oocytes for modelling neurological disease for novel drug discovery., O'Connor EC, Kambara K, Bertrand D., Expert Opin Drug Discov. February 1, 2024; 19 (2): 173-187.  |
|
Bioelectric signaling: Reprogrammable circuits underlying embryogenesis, regeneration, and cancer., Levin M., Cell. April 15, 2021;  |
|
Lack of response to quinidine in KCNT1-related neonatal epilepsy., Numis AL, Nair U, Datta AN, Sands TT, Oldham MS, Patel A, Li M, Gazina E, Petrou S, Cilio MR., Epilepsia. October 1, 2018; 59 (10): 1889-1898. |
|
Clinical and molecular characterization of KCNT1-related severe early-onset epilepsy., McTague A, Nair U, Malhotra S, Meyer E, Trump N, Gazina EV, Papandreou A, Ngoh A, Ackermann S, Ambegaonkar G, Appleton R, Desurkar A, Eltze C, Kneen R, Kumar AV, Lascelles K, Montgomery T, Ramesh V, Samanta R, Scott RH, Tan J, Whitehouse W, Poduri A, Scheffer IE, Chong WKK, Cross JH, Topf M, Petrou S, Kurian MA., Neurology. January 2, 2018; 90 (1): e55-e66.  |
|
Human slack potassium channel mutations increase positive cooperativity between individual channels., Kim GE, Kronengold J, Barcia G, Quraishi IH, Martin HC, Blair E, Taylor JC, Dulac O, Colleaux L, Nabbout R, Kaczmarek LK., Cell Rep. December 11, 2014; 9 (5): 1661-1672.  |
???pagination.result.page??? 1